Nearly 1,650 people in the U.S. are awaiting lung transplants. Unfortunately, both domestically and abroad, the demand for donor lungs far outpaces the supply. The limited availability of donor lungs ...
Health and Me on MSN
Small-cell lung cancer is one of the hardest cancers to treat: What this new drug combination could change
Amgen and AstraZeneca, a new drug combination has shown promise in the delaying the return and progression of small-cell lung cancer.
Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells to target tumors. TIL therapy, now FDA-approved for solid tumors, shows ...
T-cell redirecting platforms function by enabling antigen-specific recognition or by colocalizing effector T cells with tumor ...
Frost & Sullivan officially unveils the 2026 Global Stem Cell Industry Development Blue Book, providing an in-depth analysis of the global stem cell industry. The report comprehensively examines the ...
The Cool Down on MSN
UK study finds heavy metals can cause lung cancer cells to better resist chemotherapy
The researchers also found that the effect could be reversed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results